nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltitrexed—TYMS—Capecitabine—kidney cancer	0.433	0.591	CbGbCtD
Raltitrexed—TYMS—Gemcitabine—kidney cancer	0.3	0.409	CbGbCtD
Raltitrexed—FPGS—Fluoropyrimidine Activity—PPAT—kidney cancer	0.0074	0.157	CbGpPWpGaD
Raltitrexed—TYMS—Fluoropyrimidine Activity—PPAT—kidney cancer	0.0027	0.0573	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.00237	0.0502	CbGpPWpGaD
Raltitrexed—FPGS—Everolimus—Temsirolimus—kidney cancer	0.00222	0.355	CbGdCrCtD
Raltitrexed—TYMS—E2F transcription factor network—TFE3—kidney cancer	0.00149	0.0316	CbGpPWpGaD
Raltitrexed—TYMS—Nucleotide metabolism—PPAT—kidney cancer	0.00136	0.0288	CbGpPWpGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—kidney cancer	0.00132	0.0279	CbGpPWpGaD
Raltitrexed—TYMS—Nucleotide metabolism—APRT—kidney cancer	0.00126	0.0267	CbGpPWpGaD
Raltitrexed—TYMS—Docetaxel—Paclitaxel—kidney cancer	0.00108	0.174	CbGdCrCtD
Raltitrexed—TYMS—E2F transcription factor network—APAF1—kidney cancer	0.000805	0.0171	CbGpPWpGaD
Raltitrexed—FPGS—Fluoropyrimidine Activity—TP53—kidney cancer	0.000735	0.0156	CbGpPWpGaD
Raltitrexed—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—kidney cancer	0.000569	0.0121	CbGpPWpGaD
Raltitrexed—TYMS—Sirolimus—Temsirolimus—kidney cancer	0.000521	0.0836	CbGdCrCtD
Raltitrexed—TYMS—Sirolimus—Everolimus—kidney cancer	0.000521	0.0836	CbGdCrCtD
Raltitrexed—TYMS—Gefitinib—Erlotinib—kidney cancer	0.000519	0.0833	CbGdCrCtD
Raltitrexed—FPGS—Metabolism—ACY1—kidney cancer	0.000487	0.0103	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CCBL1—kidney cancer	0.000465	0.00987	CbGpPWpGaD
Raltitrexed—TYMS—G1/S Transition—PSMD7—kidney cancer	0.000443	0.0094	CbGpPWpGaD
Raltitrexed—FPGS—Disease—AMER1—kidney cancer	0.000421	0.00893	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PDHB—kidney cancer	0.000414	0.0088	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—SYNE2—kidney cancer	0.000414	0.00878	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—HNF1B—kidney cancer	0.00041	0.00869	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—KCNMA1—kidney cancer	0.000399	0.00847	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—CCBL1—kidney cancer	0.00039	0.00827	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—PSMD7—kidney cancer	0.000373	0.00792	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000373	0.00792	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000373	0.00792	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—JUND—kidney cancer	0.000358	0.0076	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000354	0.0075	CbGpPWpGaD
Raltitrexed—FPGS—Disease—GPC3—kidney cancer	0.000353	0.00748	CbGpPWpGaD
Raltitrexed—TYMS—Vinorelbine—Vinblastine—kidney cancer	0.000348	0.0558	CbGdCrCtD
Raltitrexed—TYMS—Vinorelbine—Vincristine—kidney cancer	0.000348	0.0558	CbGdCrCtD
Raltitrexed—FPGS—Metabolism—GLIPR1—kidney cancer	0.000338	0.00717	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PPAT—kidney cancer	0.000338	0.00717	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ST3GAL2—kidney cancer	0.000326	0.00692	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—FH—kidney cancer	0.000314	0.00667	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—APRT—kidney cancer	0.000314	0.00667	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000308	0.00653	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PGK1—kidney cancer	0.000306	0.00649	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SLC5A3—kidney cancer	0.000306	0.00649	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SFRP2—kidney cancer	0.0003	0.00636	CbGpPWpGaD
Raltitrexed—FPGS—Disease—LDHB—kidney cancer	0.0003	0.00636	CbGpPWpGaD
Raltitrexed—TYMS—Vincristine—Vinblastine—kidney cancer	0.000298	0.0477	CbGdCrCtD
Raltitrexed—FPGS—Metabolism—GPC3—kidney cancer	0.000295	0.00627	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Everolimus—kidney cancer	0.00029	0.00135	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Vinblastine—kidney cancer	0.000289	0.00135	CcSEcCtD
Raltitrexed—Thrombocytopenia—Sunitinib—kidney cancer	0.000288	0.00134	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Everolimus—kidney cancer	0.000288	0.00134	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CA2—kidney cancer	0.000287	0.0061	CbGpPWpGaD
Raltitrexed—Discomfort—Dactinomycin—kidney cancer	0.000287	0.00134	CcSEcCtD
Raltitrexed—Influenza like illness—Doxorubicin—kidney cancer	0.000284	0.00133	CcSEcCtD
Raltitrexed—Vomiting—Pazopanib—kidney cancer	0.000283	0.00132	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000283	0.006	CbGpPWpGaD
Raltitrexed—Anaemia—Vincristine—kidney cancer	0.000282	0.00132	CcSEcCtD
Raltitrexed—Rash—Pazopanib—kidney cancer	0.000281	0.00131	CcSEcCtD
Raltitrexed—Nausea—Temsirolimus—kidney cancer	0.000281	0.00131	CcSEcCtD
Raltitrexed—Dermatitis—Pazopanib—kidney cancer	0.000281	0.00131	CcSEcCtD
Raltitrexed—Anorexia—Sunitinib—kidney cancer	0.00028	0.00131	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ALAD—kidney cancer	0.00028	0.00594	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TCEB1—kidney cancer	0.00028	0.00593	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TCEB2—kidney cancer	0.00028	0.00593	CbGpPWpGaD
Raltitrexed—Skin exfoliation—Doxorubicin—kidney cancer	0.00028	0.00131	CcSEcCtD
Raltitrexed—Abdominal pain—Vinblastine—kidney cancer	0.000279	0.0013	CcSEcCtD
Raltitrexed—Headache—Pazopanib—kidney cancer	0.000279	0.0013	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000278	0.0013	CcSEcCtD
Raltitrexed—Oedema—Dactinomycin—kidney cancer	0.000278	0.0013	CcSEcCtD
Raltitrexed—Body temperature increased—Everolimus—kidney cancer	0.000278	0.0013	CcSEcCtD
Raltitrexed—Abdominal pain—Everolimus—kidney cancer	0.000278	0.0013	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Erlotinib—kidney cancer	0.000278	0.0013	CcSEcCtD
Raltitrexed—Infection—Dactinomycin—kidney cancer	0.000276	0.00129	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ST3GAL2—kidney cancer	0.000273	0.0058	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	0.000273	0.00579	CbGpPWpGaD
Raltitrexed—Leukopenia—Vincristine—kidney cancer	0.000273	0.00127	CcSEcCtD
Raltitrexed—Thrombocytopenia—Dactinomycin—kidney cancer	0.000272	0.00127	CcSEcCtD
Raltitrexed—Dyspepsia—Sorafenib—kidney cancer	0.000269	0.00126	CcSEcCtD
Raltitrexed—Body temperature increased—Erlotinib—kidney cancer	0.000268	0.00125	CcSEcCtD
Raltitrexed—Abdominal pain—Erlotinib—kidney cancer	0.000268	0.00125	CcSEcCtD
Raltitrexed—Ill-defined disorder—Gemcitabine—kidney cancer	0.000268	0.00125	CcSEcCtD
Raltitrexed—TYMS—Fluoropyrimidine Activity—TP53—kidney cancer	0.000268	0.00568	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000268	0.00125	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ALDH1A1—kidney cancer	0.000267	0.00567	CbGpPWpGaD
Raltitrexed—Anaemia—Gemcitabine—kidney cancer	0.000267	0.00125	CcSEcCtD
Raltitrexed—Neutropenia—Capecitabine—kidney cancer	0.000266	0.00124	CcSEcCtD
Raltitrexed—Decreased appetite—Sorafenib—kidney cancer	0.000266	0.00124	CcSEcCtD
Raltitrexed—Anorexia—Dactinomycin—kidney cancer	0.000265	0.00124	CcSEcCtD
Raltitrexed—Nausea—Pazopanib—kidney cancer	0.000265	0.00124	CcSEcCtD
Raltitrexed—Mouth ulceration—Doxorubicin—kidney cancer	0.000265	0.00124	CcSEcCtD
Raltitrexed—Constipation—Sorafenib—kidney cancer	0.000261	0.00122	CcSEcCtD
Raltitrexed—Pain—Sorafenib—kidney cancer	0.000261	0.00122	CcSEcCtD
Raltitrexed—Malaise—Gemcitabine—kidney cancer	0.000261	0.00122	CcSEcCtD
Raltitrexed—Dyspepsia—Sunitinib—kidney cancer	0.000259	0.00121	CcSEcCtD
Raltitrexed—Leukopenia—Gemcitabine—kidney cancer	0.000259	0.00121	CcSEcCtD
Raltitrexed—Weight decreased—Capecitabine—kidney cancer	0.000258	0.0012	CcSEcCtD
Raltitrexed—Hypertonia—Doxorubicin—kidney cancer	0.000257	0.0012	CcSEcCtD
Raltitrexed—FPGS—Metabolism—SLC5A3—kidney cancer	0.000256	0.00543	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PGK1—kidney cancer	0.000256	0.00543	CbGpPWpGaD
Raltitrexed—Decreased appetite—Sunitinib—kidney cancer	0.000256	0.00119	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—CDKN2A—kidney cancer	0.000255	0.00541	CbGpPWpGaD
Raltitrexed—Sepsis—Doxorubicin—kidney cancer	0.000254	0.00119	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000254	0.00539	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000254	0.00539	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000254	0.00118	CcSEcCtD
Raltitrexed—Asthenia—Vinblastine—kidney cancer	0.000253	0.00118	CcSEcCtD
Raltitrexed—Asthenia—Everolimus—kidney cancer	0.000252	0.00118	CcSEcCtD
Raltitrexed—Cough—Gemcitabine—kidney cancer	0.000252	0.00118	CcSEcCtD
Raltitrexed—Pain—Sunitinib—kidney cancer	0.000251	0.00117	CcSEcCtD
Raltitrexed—Constipation—Sunitinib—kidney cancer	0.000251	0.00117	CcSEcCtD
Raltitrexed—FPGS—Metabolism—LDHB—kidney cancer	0.000251	0.00533	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Sorafenib—kidney cancer	0.00025	0.00117	CcSEcCtD
Raltitrexed—Renal failure—Capecitabine—kidney cancer	0.00025	0.00117	CcSEcCtD
Raltitrexed—Pruritus—Everolimus—kidney cancer	0.000249	0.00116	CcSEcCtD
Raltitrexed—Oedema—Vincristine—kidney cancer	0.000249	0.00116	CcSEcCtD
Raltitrexed—Arrhythmia—Paclitaxel—kidney cancer	0.000248	0.00116	CcSEcCtD
Raltitrexed—Stomatitis—Capecitabine—kidney cancer	0.000248	0.00116	CcSEcCtD
Raltitrexed—Infection—Vincristine—kidney cancer	0.000247	0.00115	CcSEcCtD
Raltitrexed—Conjunctivitis—Capecitabine—kidney cancer	0.000247	0.00115	CcSEcCtD
Raltitrexed—Arthralgia—Gemcitabine—kidney cancer	0.000246	0.00115	CcSEcCtD
Raltitrexed—Alopecia—Paclitaxel—kidney cancer	0.000246	0.00115	CcSEcCtD
Raltitrexed—Asthenia—Erlotinib—kidney cancer	0.000244	0.00114	CcSEcCtD
Raltitrexed—Thrombocytopenia—Vincristine—kidney cancer	0.000243	0.00114	CcSEcCtD
Raltitrexed—Discomfort—Gemcitabine—kidney cancer	0.000243	0.00114	CcSEcCtD
Raltitrexed—Decreased appetite—Dactinomycin—kidney cancer	0.000242	0.00113	CcSEcCtD
Raltitrexed—Diarrhoea—Vinblastine—kidney cancer	0.000242	0.00113	CcSEcCtD
Raltitrexed—Abdominal pain—Sorafenib—kidney cancer	0.000241	0.00113	CcSEcCtD
Raltitrexed—Body temperature increased—Sorafenib—kidney cancer	0.000241	0.00113	CcSEcCtD
Raltitrexed—Diarrhoea—Everolimus—kidney cancer	0.000241	0.00112	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Sunitinib—kidney cancer	0.00024	0.00112	CcSEcCtD
Raltitrexed—Hyperhidrosis—Vincristine—kidney cancer	0.00024	0.00112	CcSEcCtD
Raltitrexed—Pruritus—Erlotinib—kidney cancer	0.00024	0.00112	CcSEcCtD
Raltitrexed—TYMS—Vinblastine—Vincristine—kidney cancer	0.000239	0.0384	CbGdCrCtD
Raltitrexed—Pain—Dactinomycin—kidney cancer	0.000238	0.00111	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000237	0.00504	CbGpPWpGaD
Raltitrexed—Anorexia—Vincristine—kidney cancer	0.000237	0.00111	CcSEcCtD
Raltitrexed—Dysgeusia—Paclitaxel—kidney cancer	0.000237	0.00111	CcSEcCtD
Raltitrexed—Hepatic failure—Doxorubicin—kidney cancer	0.000236	0.0011	CcSEcCtD
Raltitrexed—Oedema—Gemcitabine—kidney cancer	0.000236	0.0011	CcSEcCtD
Raltitrexed—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000234	0.00109	CcSEcCtD
Raltitrexed—Infection—Gemcitabine—kidney cancer	0.000234	0.00109	CcSEcCtD
Raltitrexed—Abdominal pain—Sunitinib—kidney cancer	0.000232	0.00109	CcSEcCtD
Raltitrexed—Body temperature increased—Sunitinib—kidney cancer	0.000232	0.00109	CcSEcCtD
Raltitrexed—Diarrhoea—Erlotinib—kidney cancer	0.000232	0.00109	CcSEcCtD
Raltitrexed—Thrombocytopenia—Gemcitabine—kidney cancer	0.000231	0.00108	CcSEcCtD
Raltitrexed—Feeling abnormal—Dactinomycin—kidney cancer	0.000229	0.00107	CcSEcCtD
Raltitrexed—Hyperhidrosis—Gemcitabine—kidney cancer	0.000228	0.00107	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—EGR1—kidney cancer	0.000228	0.00484	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000228	0.00106	CcSEcCtD
Raltitrexed—FPGS—Disease—RPL14—kidney cancer	0.000227	0.00482	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000227	0.00106	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—CDKN1B—kidney cancer	0.000226	0.00479	CbGpPWpGaD
Raltitrexed—Anorexia—Gemcitabine—kidney cancer	0.000225	0.00105	CcSEcCtD
Raltitrexed—Vomiting—Vinblastine—kidney cancer	0.000225	0.00105	CcSEcCtD
Raltitrexed—Ill-defined disorder—Paclitaxel—kidney cancer	0.000224	0.00105	CcSEcCtD
Raltitrexed—Vomiting—Everolimus—kidney cancer	0.000224	0.00105	CcSEcCtD
Raltitrexed—Anaemia—Paclitaxel—kidney cancer	0.000224	0.00104	CcSEcCtD
Raltitrexed—Renal impairment—Doxorubicin—kidney cancer	0.000223	0.00104	CcSEcCtD
Raltitrexed—Rash—Everolimus—kidney cancer	0.000222	0.00104	CcSEcCtD
Raltitrexed—Dermatitis—Everolimus—kidney cancer	0.000222	0.00104	CcSEcCtD
Raltitrexed—Headache—Vinblastine—kidney cancer	0.000221	0.00103	CcSEcCtD
Raltitrexed—Headache—Everolimus—kidney cancer	0.00022	0.00103	CcSEcCtD
Raltitrexed—Body temperature increased—Dactinomycin—kidney cancer	0.00022	0.00103	CcSEcCtD
Raltitrexed—Abdominal pain—Dactinomycin—kidney cancer	0.00022	0.00103	CcSEcCtD
Raltitrexed—Asthenia—Sorafenib—kidney cancer	0.000219	0.00102	CcSEcCtD
Raltitrexed—Malaise—Paclitaxel—kidney cancer	0.000218	0.00102	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CA9—kidney cancer	0.000218	0.00462	CbGpPWpGaD
Raltitrexed—Leukopenia—Paclitaxel—kidney cancer	0.000217	0.00101	CcSEcCtD
Raltitrexed—Decreased appetite—Vincristine—kidney cancer	0.000216	0.00101	CcSEcCtD
Raltitrexed—Pruritus—Sorafenib—kidney cancer	0.000216	0.00101	CcSEcCtD
Raltitrexed—Vomiting—Erlotinib—kidney cancer	0.000216	0.00101	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000215	0.001	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	0.000214	0.00455	CbGpPWpGaD
Raltitrexed—Rash—Erlotinib—kidney cancer	0.000214	0.001	CcSEcCtD
Raltitrexed—Dermatitis—Erlotinib—kidney cancer	0.000214	0.000999	CcSEcCtD
Raltitrexed—Headache—Erlotinib—kidney cancer	0.000213	0.000994	CcSEcCtD
Raltitrexed—Constipation—Vincristine—kidney cancer	0.000213	0.000993	CcSEcCtD
Raltitrexed—Pain—Vincristine—kidney cancer	0.000213	0.000993	CcSEcCtD
Raltitrexed—Cough—Paclitaxel—kidney cancer	0.000211	0.000986	CcSEcCtD
Raltitrexed—Asthenia—Sunitinib—kidney cancer	0.000211	0.000985	CcSEcCtD
Raltitrexed—Nausea—Vinblastine—kidney cancer	0.00021	0.00098	CcSEcCtD
Raltitrexed—Nausea—Everolimus—kidney cancer	0.000209	0.000977	CcSEcCtD
Raltitrexed—Diarrhoea—Sorafenib—kidney cancer	0.000209	0.000976	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000208	0.00442	CbGpPWpGaD
Raltitrexed—Pruritus—Sunitinib—kidney cancer	0.000208	0.000972	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000207	0.00438	CbGpPWpGaD
Raltitrexed—Arthralgia—Paclitaxel—kidney cancer	0.000206	0.000962	CcSEcCtD
Raltitrexed—FPGS—Disease—ITPR2—kidney cancer	0.000206	0.00436	CbGpPWpGaD
Raltitrexed—Decreased appetite—Gemcitabine—kidney cancer	0.000205	0.000958	CcSEcCtD
Raltitrexed—Arrhythmia—Capecitabine—kidney cancer	0.000204	0.000952	CcSEcCtD
Raltitrexed—Discomfort—Paclitaxel—kidney cancer	0.000204	0.000951	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Vincristine—kidney cancer	0.000203	0.00095	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000202	0.00428	CbGpPWpGaD
Raltitrexed—Constipation—Gemcitabine—kidney cancer	0.000202	0.000942	CcSEcCtD
Raltitrexed—Pain—Gemcitabine—kidney cancer	0.000202	0.000942	CcSEcCtD
Raltitrexed—Nausea—Erlotinib—kidney cancer	0.000202	0.000942	CcSEcCtD
Raltitrexed—Alopecia—Capecitabine—kidney cancer	0.000202	0.000942	CcSEcCtD
Raltitrexed—Diarrhoea—Sunitinib—kidney cancer	0.000201	0.00094	CcSEcCtD
Raltitrexed—Asthenia—Dactinomycin—kidney cancer	0.0002	0.000933	CcSEcCtD
Raltitrexed—Dehydration—Doxorubicin—kidney cancer	0.000198	0.000923	CcSEcCtD
Raltitrexed—Oedema—Paclitaxel—kidney cancer	0.000197	0.000923	CcSEcCtD
Raltitrexed—Abdominal pain—Vincristine—kidney cancer	0.000197	0.000918	CcSEcCtD
Raltitrexed—Body temperature increased—Vincristine—kidney cancer	0.000197	0.000918	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	0.000196	0.00416	CbGpPWpGaD
Raltitrexed—Infection—Paclitaxel—kidney cancer	0.000196	0.000917	CcSEcCtD
Raltitrexed—Dysgeusia—Capecitabine—kidney cancer	0.000194	0.000908	CcSEcCtD
Raltitrexed—Feeling abnormal—Gemcitabine—kidney cancer	0.000194	0.000908	CcSEcCtD
Raltitrexed—Vomiting—Sorafenib—kidney cancer	0.000194	0.000907	CcSEcCtD
Raltitrexed—Thrombocytopenia—Paclitaxel—kidney cancer	0.000193	0.000903	CcSEcCtD
Raltitrexed—Rash—Sorafenib—kidney cancer	0.000193	0.0009	CcSEcCtD
Raltitrexed—Dermatitis—Sorafenib—kidney cancer	0.000192	0.000899	CcSEcCtD
Raltitrexed—Headache—Sorafenib—kidney cancer	0.000191	0.000894	CcSEcCtD
Raltitrexed—Hyperhidrosis—Paclitaxel—kidney cancer	0.000191	0.000892	CcSEcCtD
Raltitrexed—Diarrhoea—Dactinomycin—kidney cancer	0.00019	0.00089	CcSEcCtD
Raltitrexed—Anorexia—Paclitaxel—kidney cancer	0.000188	0.000879	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	0.000187	0.00397	CbGpPWpGaD
Raltitrexed—Vomiting—Sunitinib—kidney cancer	0.000187	0.000873	CcSEcCtD
Raltitrexed—Body temperature increased—Gemcitabine—kidney cancer	0.000186	0.000871	CcSEcCtD
Raltitrexed—Rash—Sunitinib—kidney cancer	0.000185	0.000866	CcSEcCtD
Raltitrexed—Dermatitis—Sunitinib—kidney cancer	0.000185	0.000865	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CRABP1—kidney cancer	0.000185	0.00393	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Capecitabine—kidney cancer	0.000184	0.000861	CcSEcCtD
Raltitrexed—Headache—Sunitinib—kidney cancer	0.000184	0.00086	CcSEcCtD
Raltitrexed—Anaemia—Capecitabine—kidney cancer	0.000184	0.000857	CcSEcCtD
Raltitrexed—Nausea—Sorafenib—kidney cancer	0.000181	0.000848	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00018	0.000841	CcSEcCtD
Raltitrexed—Malaise—Capecitabine—kidney cancer	0.000179	0.000837	CcSEcCtD
Raltitrexed—Asthenia—Vincristine—kidney cancer	0.000178	0.000833	CcSEcCtD
Raltitrexed—Leukopenia—Capecitabine—kidney cancer	0.000178	0.00083	CcSEcCtD
Raltitrexed—TYMS—Metabolism—ACY1—kidney cancer	0.000178	0.00377	CbGpPWpGaD
Raltitrexed—Vomiting—Dactinomycin—kidney cancer	0.000177	0.000827	CcSEcCtD
Raltitrexed—Rash—Dactinomycin—kidney cancer	0.000175	0.00082	CcSEcCtD
Raltitrexed—Nausea—Sunitinib—kidney cancer	0.000175	0.000816	CcSEcCtD
Raltitrexed—Dyspepsia—Paclitaxel—kidney cancer	0.000174	0.000812	CcSEcCtD
Raltitrexed—Cough—Capecitabine—kidney cancer	0.000173	0.000809	CcSEcCtD
Raltitrexed—TYMS—E2F transcription factor network—MYC—kidney cancer	0.000173	0.00367	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PSMD7—kidney cancer	0.000172	0.00365	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ITPR2—kidney cancer	0.000172	0.00365	CbGpPWpGaD
Raltitrexed—Neutropenia—Doxorubicin—kidney cancer	0.000172	0.000802	CcSEcCtD
Raltitrexed—Decreased appetite—Paclitaxel—kidney cancer	0.000172	0.000802	CcSEcCtD
Raltitrexed—Diarrhoea—Vincristine—kidney cancer	0.00017	0.000795	CcSEcCtD
Raltitrexed—Asthenia—Gemcitabine—kidney cancer	0.000169	0.000791	CcSEcCtD
Raltitrexed—Arthralgia—Capecitabine—kidney cancer	0.000169	0.00079	CcSEcCtD
Raltitrexed—Pain—Paclitaxel—kidney cancer	0.000169	0.000789	CcSEcCtD
Raltitrexed—Constipation—Paclitaxel—kidney cancer	0.000169	0.000789	CcSEcCtD
Raltitrexed—Discomfort—Capecitabine—kidney cancer	0.000167	0.00078	CcSEcCtD
Raltitrexed—Pruritus—Gemcitabine—kidney cancer	0.000167	0.00078	CcSEcCtD
Raltitrexed—Weight decreased—Doxorubicin—kidney cancer	0.000166	0.000776	CcSEcCtD
Raltitrexed—Nausea—Dactinomycin—kidney cancer	0.000165	0.000772	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—CDKN1B—kidney cancer	0.000164	0.00348	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Paclitaxel—kidney cancer	0.000163	0.00076	CcSEcCtD
Raltitrexed—Oedema—Capecitabine—kidney cancer	0.000162	0.000757	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000161	0.000754	CcSEcCtD
Raltitrexed—Diarrhoea—Gemcitabine—kidney cancer	0.000161	0.000754	CcSEcCtD
Raltitrexed—Renal failure—Doxorubicin—kidney cancer	0.000161	0.000752	CcSEcCtD
Raltitrexed—Infection—Capecitabine—kidney cancer	0.000161	0.000752	CcSEcCtD
Raltitrexed—Stomatitis—Doxorubicin—kidney cancer	0.00016	0.000746	CcSEcCtD
Raltitrexed—Conjunctivitis—Doxorubicin—kidney cancer	0.000159	0.000744	CcSEcCtD
Raltitrexed—Thrombocytopenia—Capecitabine—kidney cancer	0.000159	0.000741	CcSEcCtD
Raltitrexed—Vomiting—Vincristine—kidney cancer	0.000158	0.000739	CcSEcCtD
Raltitrexed—Sweating—Doxorubicin—kidney cancer	0.000157	0.000734	CcSEcCtD
Raltitrexed—FPGS—Metabolism—GSTT1—kidney cancer	0.000157	0.00333	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—ACHE—kidney cancer	0.000157	0.00333	CbGpPWpGaD
Raltitrexed—Rash—Vincristine—kidney cancer	0.000157	0.000732	CcSEcCtD
Raltitrexed—Hyperhidrosis—Capecitabine—kidney cancer	0.000157	0.000732	CcSEcCtD
Raltitrexed—Dermatitis—Vincristine—kidney cancer	0.000157	0.000732	CcSEcCtD
Raltitrexed—Abdominal pain—Paclitaxel—kidney cancer	0.000156	0.000729	CcSEcCtD
Raltitrexed—Body temperature increased—Paclitaxel—kidney cancer	0.000156	0.000729	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	0.000156	0.00331	CbGpPWpGaD
Raltitrexed—FPGS—Disease—SLC2A1—kidney cancer	0.000156	0.00331	CbGpPWpGaD
Raltitrexed—Headache—Vincristine—kidney cancer	0.000156	0.000728	CcSEcCtD
Raltitrexed—FPGS—Disease—JUNB—kidney cancer	0.000155	0.00328	CbGpPWpGaD
Raltitrexed—Anorexia—Capecitabine—kidney cancer	0.000154	0.000722	CcSEcCtD
Raltitrexed—TYMS—Metabolism—PDHB—kidney cancer	0.000151	0.00321	CbGpPWpGaD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	0.00015	0.00319	CbGpPWpGaD
Raltitrexed—Vomiting—Gemcitabine—kidney cancer	0.00015	0.000701	CcSEcCtD
Raltitrexed—Rash—Gemcitabine—kidney cancer	0.000149	0.000695	CcSEcCtD
Raltitrexed—FPGS—Metabolism—SCARB1—kidney cancer	0.000149	0.00315	CbGpPWpGaD
Raltitrexed—Dermatitis—Gemcitabine—kidney cancer	0.000149	0.000694	CcSEcCtD
Raltitrexed—Headache—Gemcitabine—kidney cancer	0.000148	0.00069	CcSEcCtD
Raltitrexed—Nausea—Vincristine—kidney cancer	0.000148	0.00069	CcSEcCtD
Raltitrexed—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000148	0.00069	CcSEcCtD
Raltitrexed—FPGS—Metabolism—PTGS1—kidney cancer	0.000147	0.00312	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000146	0.00309	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PSMD7—kidney cancer	0.000144	0.00306	CbGpPWpGaD
Raltitrexed—Dyspepsia—Capecitabine—kidney cancer	0.000143	0.000666	CcSEcCtD
Raltitrexed—TYMS—Metabolism—CCBL1—kidney cancer	0.000142	0.00301	CbGpPWpGaD
Raltitrexed—Asthenia—Paclitaxel—kidney cancer	0.000142	0.000662	CcSEcCtD
Raltitrexed—Decreased appetite—Capecitabine—kidney cancer	0.000141	0.000658	CcSEcCtD
Raltitrexed—TYMS—Azacitidine—Gemcitabine—kidney cancer	0.00014	0.0225	CbGdCrCtD
Raltitrexed—Nausea—Gemcitabine—kidney cancer	0.00014	0.000655	CcSEcCtD
Raltitrexed—Pruritus—Paclitaxel—kidney cancer	0.00014	0.000653	CcSEcCtD
Raltitrexed—Pain—Capecitabine—kidney cancer	0.000139	0.000647	CcSEcCtD
Raltitrexed—Constipation—Capecitabine—kidney cancer	0.000139	0.000647	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	0.000138	0.00293	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—PSMD7—kidney cancer	0.000137	0.0029	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—BCHE—kidney cancer	0.000137	0.0029	CbGpPWpGaD
Raltitrexed—Diarrhoea—Paclitaxel—kidney cancer	0.000135	0.000631	CcSEcCtD
Raltitrexed—FPGS—Metabolism—SLC5A5—kidney cancer	0.000135	0.00287	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Capecitabine—kidney cancer	0.000134	0.000624	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle, Mitotic—AURKA—kidney cancer	0.000133	0.00283	CbGpPWpGaD
Raltitrexed—Gastrointestinal pain—Capecitabine—kidney cancer	0.000133	0.000619	CcSEcCtD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—CCND1—kidney cancer	0.000132	0.0028	CbGpPWpGaD
Raltitrexed—Arrhythmia—Doxorubicin—kidney cancer	0.000131	0.000614	CcSEcCtD
Raltitrexed—FPGS—Metabolism—SLC2A1—kidney cancer	0.00013	0.00277	CbGpPWpGaD
Raltitrexed—Alopecia—Doxorubicin—kidney cancer	0.00013	0.000607	CcSEcCtD
Raltitrexed—Body temperature increased—Capecitabine—kidney cancer	0.000128	0.000598	CcSEcCtD
Raltitrexed—Abdominal pain—Capecitabine—kidney cancer	0.000128	0.000598	CcSEcCtD
Raltitrexed—FPGS—Disease—CDKN2B—kidney cancer	0.000126	0.00267	CbGpPWpGaD
Raltitrexed—Vomiting—Paclitaxel—kidney cancer	0.000126	0.000587	CcSEcCtD
Raltitrexed—TYMS—G1/S Transition—MYC—kidney cancer	0.000125	0.00266	CbGpPWpGaD
Raltitrexed—Dysgeusia—Doxorubicin—kidney cancer	0.000125	0.000586	CcSEcCtD
Raltitrexed—Rash—Paclitaxel—kidney cancer	0.000125	0.000582	CcSEcCtD
Raltitrexed—Dermatitis—Paclitaxel—kidney cancer	0.000124	0.000581	CcSEcCtD
Raltitrexed—Headache—Paclitaxel—kidney cancer	0.000124	0.000578	CcSEcCtD
Raltitrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	0.000123	0.00262	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GLIPR1—kidney cancer	0.000123	0.00261	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PPAT—kidney cancer	0.000123	0.00261	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—PSMD7—kidney cancer	0.000122	0.0026	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—AURKA—kidney cancer	0.000119	0.00253	CbGpPWpGaD
Raltitrexed—Ill-defined disorder—Doxorubicin—kidney cancer	0.000119	0.000555	CcSEcCtD
Raltitrexed—Anaemia—Doxorubicin—kidney cancer	0.000118	0.000553	CcSEcCtD
Raltitrexed—Nausea—Paclitaxel—kidney cancer	0.000117	0.000548	CcSEcCtD
Raltitrexed—Asthenia—Capecitabine—kidney cancer	0.000116	0.000543	CcSEcCtD
Raltitrexed—Malaise—Doxorubicin—kidney cancer	0.000115	0.000539	CcSEcCtD
Raltitrexed—Pruritus—Capecitabine—kidney cancer	0.000115	0.000536	CcSEcCtD
Raltitrexed—Leukopenia—Doxorubicin—kidney cancer	0.000115	0.000535	CcSEcCtD
Raltitrexed—TYMS—Metabolism—APRT—kidney cancer	0.000115	0.00243	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—FH—kidney cancer	0.000115	0.00243	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000114	0.00242	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000113	0.0024	CbGpPWpGaD
Raltitrexed—Cough—Doxorubicin—kidney cancer	0.000112	0.000522	CcSEcCtD
Raltitrexed—Diarrhoea—Capecitabine—kidney cancer	0.000111	0.000518	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.00011	0.00234	CbGpPWpGaD
Raltitrexed—Arthralgia—Doxorubicin—kidney cancer	0.000109	0.000509	CcSEcCtD
Raltitrexed—FPGS—Metabolism—GSTP1—kidney cancer	0.000109	0.00231	CbGpPWpGaD
Raltitrexed—Discomfort—Doxorubicin—kidney cancer	0.000108	0.000503	CcSEcCtD
Raltitrexed—TYMS—Metabolism—GPC3—kidney cancer	0.000108	0.00228	CbGpPWpGaD
Raltitrexed—TYMS—Mitotic G1-G1/S phases—MYC—kidney cancer	0.000106	0.00224	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CA2—kidney cancer	0.000105	0.00222	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000105	0.00222	CbGpPWpGaD
Raltitrexed—Oedema—Doxorubicin—kidney cancer	0.000104	0.000488	CcSEcCtD
Raltitrexed—Infection—Doxorubicin—kidney cancer	0.000104	0.000485	CcSEcCtD
Raltitrexed—Vomiting—Capecitabine—kidney cancer	0.000103	0.000481	CcSEcCtD
Raltitrexed—FPGS—Metabolism—ABCB1—kidney cancer	0.000103	0.00219	CbGpPWpGaD
Raltitrexed—Thrombocytopenia—Doxorubicin—kidney cancer	0.000102	0.000478	CcSEcCtD
Raltitrexed—Rash—Capecitabine—kidney cancer	0.000102	0.000477	CcSEcCtD
Raltitrexed—Dermatitis—Capecitabine—kidney cancer	0.000102	0.000477	CcSEcCtD
Raltitrexed—TYMS—Metabolism—ALAD—kidney cancer	0.000102	0.00217	CbGpPWpGaD
Raltitrexed—Headache—Capecitabine—kidney cancer	0.000102	0.000474	CcSEcCtD
Raltitrexed—Hyperhidrosis—Doxorubicin—kidney cancer	0.000101	0.000472	CcSEcCtD
Raltitrexed—FPGS—Disease—HIF1A—kidney cancer	0.000101	0.00214	CbGpPWpGaD
Raltitrexed—FPGS—Disease—TSC2—kidney cancer	0.0001	0.00213	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2B—kidney cancer	0.0001	0.00212	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—GSTM1—kidney cancer	0.0001	0.00212	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	9.98e-05	0.00212	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ST3GAL2—kidney cancer	9.96e-05	0.00211	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	9.96e-05	0.00211	CbGpPWpGaD
Raltitrexed—Anorexia—Doxorubicin—kidney cancer	9.96e-05	0.000465	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	9.88e-05	0.0021	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ALDH1A1—kidney cancer	9.74e-05	0.00207	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	9.63e-05	0.00204	CbGpPWpGaD
Raltitrexed—Nausea—Capecitabine—kidney cancer	9.63e-05	0.00045	CcSEcCtD
Raltitrexed—TYMS—Circadian rythm related genes—JUN—kidney cancer	9.56e-05	0.00203	CbGpPWpGaD
Raltitrexed—Musculoskeletal discomfort—Doxorubicin—kidney cancer	9.52e-05	0.000445	CcSEcCtD
Raltitrexed—FPGS—Metabolism—CYP1A1—kidney cancer	9.48e-05	0.00201	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PGK1—kidney cancer	9.33e-05	0.00198	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC5A3—kidney cancer	9.33e-05	0.00198	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—PTEN—kidney cancer	9.25e-05	0.00196	CbGpPWpGaD
Raltitrexed—Dyspepsia—Doxorubicin—kidney cancer	9.19e-05	0.00043	CcSEcCtD
Raltitrexed—TYMS—Metabolism—LDHB—kidney cancer	9.15e-05	0.00194	CbGpPWpGaD
Raltitrexed—Decreased appetite—Doxorubicin—kidney cancer	9.08e-05	0.000424	CcSEcCtD
Raltitrexed—TYMS—Cell Cycle—BRCA2—kidney cancer	9.02e-05	0.00191	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN2B—kidney cancer	8.94e-05	0.0019	CbGpPWpGaD
Raltitrexed—Constipation—Doxorubicin—kidney cancer	8.93e-05	0.000417	CcSEcCtD
Raltitrexed—Pain—Doxorubicin—kidney cancer	8.93e-05	0.000417	CcSEcCtD
Raltitrexed—FPGS—Disease—KIT—kidney cancer	8.86e-05	0.00188	CbGpPWpGaD
Raltitrexed—FPGS—Disease—APC—kidney cancer	8.86e-05	0.00188	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	8.7e-05	0.00185	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—BIRC5—kidney cancer	8.63e-05	0.00183	CbGpPWpGaD
Raltitrexed—Feeling abnormal—Doxorubicin—kidney cancer	8.61e-05	0.000402	CcSEcCtD
Raltitrexed—Gastrointestinal pain—Doxorubicin—kidney cancer	8.54e-05	0.000399	CcSEcCtD
Raltitrexed—FPGS—Disease—BRAF—kidney cancer	8.33e-05	0.00177	CbGpPWpGaD
Raltitrexed—Body temperature increased—Doxorubicin—kidney cancer	8.26e-05	0.000386	CcSEcCtD
Raltitrexed—Abdominal pain—Doxorubicin—kidney cancer	8.26e-05	0.000386	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	8.23e-05	0.00175	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	8.01e-05	0.0017	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CA9—kidney cancer	7.94e-05	0.00168	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.83e-05	0.00166	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—BIRC5—kidney cancer	7.72e-05	0.00164	CbGpPWpGaD
Raltitrexed—Asthenia—Doxorubicin—kidney cancer	7.49e-05	0.00035	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.4e-05	0.00157	CbGpPWpGaD
Raltitrexed—Pruritus—Doxorubicin—kidney cancer	7.39e-05	0.000345	CcSEcCtD
Raltitrexed—Diarrhoea—Doxorubicin—kidney cancer	7.15e-05	0.000334	CcSEcCtD
Raltitrexed—FPGS—Metabolism—POMC—kidney cancer	7.07e-05	0.0015	CbGpPWpGaD
Raltitrexed—FPGS—Disease—RAF1—kidney cancer	6.96e-05	0.00148	CbGpPWpGaD
Raltitrexed—FPGS—Disease—ERBB2—kidney cancer	6.88e-05	0.00146	CbGpPWpGaD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.8e-05	0.00144	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MTOR—kidney cancer	6.79e-05	0.00144	CbGpPWpGaD
Raltitrexed—FPGS—Disease—CD4—kidney cancer	6.78e-05	0.00144	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CRABP1—kidney cancer	6.75e-05	0.00143	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTGS2—kidney cancer	6.73e-05	0.00143	CbGpPWpGaD
Raltitrexed—Vomiting—Doxorubicin—kidney cancer	6.64e-05	0.00031	CcSEcCtD
Raltitrexed—Rash—Doxorubicin—kidney cancer	6.59e-05	0.000308	CcSEcCtD
Raltitrexed—Dermatitis—Doxorubicin—kidney cancer	6.58e-05	0.000307	CcSEcCtD
Raltitrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.58e-05	0.0014	CbGpPWpGaD
Raltitrexed—Headache—Doxorubicin—kidney cancer	6.54e-05	0.000306	CcSEcCtD
Raltitrexed—FPGS—Disease—CDKN1B—kidney cancer	6.37e-05	0.00135	CbGpPWpGaD
Raltitrexed—TYMS—Circadian rythm related genes—TP53—kidney cancer	6.31e-05	0.00134	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ITPR2—kidney cancer	6.27e-05	0.00133	CbGpPWpGaD
Raltitrexed—Nausea—Doxorubicin—kidney cancer	6.2e-05	0.00029	CcSEcCtD
Raltitrexed—FPGS—Disease—CTNNB1—kidney cancer	6.02e-05	0.00128	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PTEN—kidney cancer	5.87e-05	0.00125	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTT1—kidney cancer	5.72e-05	0.00121	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ACHE—kidney cancer	5.72e-05	0.00121	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—kidney cancer	5.72e-05	0.00121	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTGS2—kidney cancer	5.64e-05	0.0012	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SCARB1—kidney cancer	5.42e-05	0.00115	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTGS1—kidney cancer	5.36e-05	0.00114	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PSMD7—kidney cancer	5.26e-05	0.00112	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN2A—kidney cancer	5.11e-05	0.00109	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CDKN1B—kidney cancer	5.07e-05	0.00107	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MAPK3—kidney cancer	5.01e-05	0.00106	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—BCHE—kidney cancer	4.98e-05	0.00106	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC5A5—kidney cancer	4.92e-05	0.00104	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PTEN—kidney cancer	4.92e-05	0.00104	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MYC—kidney cancer	4.88e-05	0.00103	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—CCND1—kidney cancer	4.83e-05	0.00103	CbGpPWpGaD
Raltitrexed—FPGS—Disease—MAPK1—kidney cancer	4.77e-05	0.00101	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—SLC2A1—kidney cancer	4.75e-05	0.00101	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CDKN1B—kidney cancer	4.53e-05	0.000961	CbGpPWpGaD
Raltitrexed—FPGS—Disease—KRAS—kidney cancer	4.51e-05	0.000956	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—CCND1—kidney cancer	4.32e-05	0.000917	CbGpPWpGaD
Raltitrexed—FPGS—Disease—PIK3CA—kidney cancer	4.14e-05	0.000879	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MAPK3—kidney cancer	3.99e-05	0.000846	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTP1—kidney cancer	3.97e-05	0.000841	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MYC—kidney cancer	3.88e-05	0.000822	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle, Mitotic—MAPK1—kidney cancer	3.79e-05	0.000805	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—ABCB1—kidney cancer	3.75e-05	0.000797	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—GSTM1—kidney cancer	3.64e-05	0.000773	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MAPK3—kidney cancer	3.56e-05	0.000756	CbGpPWpGaD
Raltitrexed—FPGS—Metabolism—PIK3CA—kidney cancer	3.47e-05	0.000736	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MYC—kidney cancer	3.47e-05	0.000735	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—CYP1A1—kidney cancer	3.45e-05	0.000733	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—MAPK1—kidney cancer	3.39e-05	0.000719	CbGpPWpGaD
Raltitrexed—TYMS—Cell Cycle—TP53—kidney cancer	2.85e-05	0.000604	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—POMC—kidney cancer	2.58e-05	0.000547	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTGS2—kidney cancer	2.05e-05	0.000436	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PTEN—kidney cancer	1.79e-05	0.00038	CbGpPWpGaD
Raltitrexed—TYMS—Metabolism—PIK3CA—kidney cancer	1.26e-05	0.000268	CbGpPWpGaD
